Chemical Inhibition of Matrix Metalloproteinases for Periodontal Treatment

Author(s): Nurdan Ozmeric, Ceren Gokmenoglu.

Journal Name: Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued)

Volume 2 , Issue 1 , 2015

Submit Manuscript
Submit Proposal

Graphical Abstract:


Abstract:

Matrix metalloproteinases (MMPs) are host-cell derived enzymes that mediate the breakdown of the connective tissue. This enzyme family takes part in many inflammatory, malignant and degenerative diseases such as cancer, cardiovascular and periodontal diseases. MMPs can be inhibited by several inhibitors. These inhibititors can be divided into two categories as synthetic and nonsynthetic molecules. The major group of non-synthetic molecules are tissue inhibitors of matrix metalloproteinases, which are produced by the same cells responsible for MMP production. Synthetic inhibitors are listed under four categories as collagen peptidomimetics, non-peptidomimetics, tetracycline and its derivatives, and biphosphonates. Among these inhibitors, subantimicrobial dose doxycycline is the only MMP inhibitor approved by Food and Drug Administration and use for the treatment of periodontitis.

Keywords: Biphosphonates, matrix metalloproteinases, MMP inhibition, peptidomimetics, tetracycline, TIMP.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 2
ISSUE: 1
Year: 2015
Page: [21 - 26]
Pages: 6
DOI: 10.2174/221270380201160517185703

Article Metrics

PDF: 14